• Like
  • Comment
  • Favorite

Ginkgo Bioworks stock pops as company plans Merck collaboration

Dow Jones2023-08-07

MW Ginkgo Bioworks stock pops as company plans Merck collaboration

Ginkgo Bioworks Holdings Inc. shares $(DNA.AU)$ were rising more than 5% in Monday's premarket trading after the company said it was collaborating with Merck & Co. Inc. $(MRK)$ on improvements in biologic manufacturing. Ginkgo plans to use its abilities in cell engineering, ultra high-throughput multiplexed screening, protein characterization and process optimization to boost yields and drive improvements in production efficiency. The company is eligible to rake in an aggregate total of $490 million in upfront research fees, research milestone fees, option license payments and commercial milestone payments, according to its release.

-Emily Bary

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 07, 2023 07:24 ET (11:24 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial